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ABSTRACT 
Mono(nucleobase) complexes of general composition cis-PtCl2(NH3)L with L = 1-methylcytosine, 1-MeC (1a) and L = 1-
ethyl-5-methylcytosine, as well as trans-[PtX2(NH3)(1-MeC)] with X = I (5a) and X = Br (5b), have been isolated and 
were characterized by X-ray crystallography. The Pt coordination occurs through N3 atom of the cytosine in all cases. 
The diaqua complexes of compounds 1a and 5a, cis-[Pt(H2O)2(NH3)(1-MeC)]
2+
 and trans-[Pt(H2O)2(NH3)(1-MeC)]
2+
 
display a rich chemistry in aqueous solution, which is dominated by extensive reactions leading to µ-OH and µ-(1-
MeC
–
-N3,N4) bridged species and ready oxidation of Pt to mixed-valence state complexes as well as diplatinum(III) 
compounds, one of which was characterized by X-ray crystallography: h,t-[{Pt(NH3)2(OH)(1-MeC
–
-
N3,N4)}2](NO3)2·2[NH4](NO3)·2H2O. A combination of 
1
H NMR spectroscopy and ESI mass spectrometry was applied to 
identify some of the various species present in solution and the gas phase, respectively. As it turned out, mass 
spectrometry did not permit an unambiguous assignment of the structures of +1 cations due to the possibilities of 
realizing multiple bridging patterns in isomeric species, the occurrence of different tautomers, and uncertainties 
regarding the Pt oxidation states. Additionally, compound 1a was found to have selective and moderate 
antiproliferative activity for a human cervix cancer line (SISO) compared to six other human cancer cell lines. 
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Introduction 
Among the great surprises research on antitumor–
active Pt coordination compounds has provided over 
the past decades are findings, that most of the “rules of 
thumb” regarding the activity of Pt complexes, coined 
during the early days of work on the structure-activity 
relationships of cisplatin,
[1]
 found their exceptions.
[2]
 
Cases include the following examples: i) Substitution of 
one of the two ammonia ligands of Cisplatin by a N-
heterocyclic ligand without any hydrogen bond donor 
ability can retain its activity. Picoplatin, in which 2-2-
methylpyridydine (2-picoline) replaces a NH3 ligand, is a 
prime example.
[3]
 ii) Even the corresponding trans-
isomer displays activity against cancer cell lines,
[4]
 
despite the fact that the trans isomer of cisplatin, that 
is, trans-[PtCl2(NH3)2], is hardly active. iii) Substitution 
of a chlorido ligand of cisplatin (or structural analogues) 
by N-heterocyclic ligands L,
[5]
 which generates cationic 
and monofunctional Pt species of general formula cis-
[PtCl(NH3)2(L)]
+
 also leads to active compounds. 
Interestingly, the first complex of this type showing 
antitumor activity, contained the pyrimidine parent 
nucleobase cytosine.
[5a,5b]
 A related example, with the 
two ammonia ligands replaced by a chelating 2,9-
dimethyl-1,10-phenanthroline ligand, chloride by 
iodide, and L being the model nucleobase 1-
methylcytosine, was later reported to have a distinctly 
different mode of action than cisplatin and to 
overcome Cisplatin resistance.
[5d]
 
Reasons for these “exceptions” probably are 
diverse: Thus, it has been proposed that the activity of 
picoplatin is the consequence of an altered, namely 
slowed-down hydrolytic activation of the Pt drug due 
to steric crowding about the Pt center as caused by the 
ortho substituent of the pyridine ligand,
[6]
 and the 
activity
 
of the cationic [PtCl(NH3)2(L)]
+
 has been 
attributed to its unique monofunctional coordination 
pattern to the putative DNA target molecule.
[7]
 
Our interest in studying complexes of types i) and ii) 
and their hydrolyzed derivatives, respectively, with the 
N-heterocycle being 1-methylcytosine (1-MeC) 
originated, apart from the feasibility to have active 
compounds in hands, from our wish to obtain a deeper 
understanding of acid-base properties of Pt-aqua 
groups in dependence of the microenvironment,
[8]
 and 
to extend our knowledge on condensation patterns 
leading to higher nuclearity clusters.
[9]
 Compounds of 
type iii) finally have been widely applied by us as 
precursors for the preparation of models of cisplatin–
DNA adducts with two identical or different 
nucleobases
[10]
 or even tris(nucleobase) adducts.
[11]
 
Figure 1 lists the three groups of active Pt complexes 
i)–iii) derived from cisplatin and its trans isomer, as well 
as the two 1-MeC complexes studied in this paper. 
 
 
Figure 1. Cisplatin (top), active complexes with single N-heterocyclic 
ligands (middle), and 1-methylcytosine (1-MeC) compounds (bottom) 
studied in this work. 
Results and Discussion 
cis-[PtCl2(NH3)(1-MeC-N3)] (1a) and cis-[PtCl2(NH3)(1-
Et-5-MeC-N3)]·H2O (1b) 
The two compounds 1a and 1b were prepared by 
treating [PtCl3(NH3)]
–
 with 1-MeC and 1-Et-5-MeC, 
respectively, in the presence of excess NaCl. NaCl was 
applied in order to avoid further reaction to bis- and 
tris-cytosine complexes. Only compound 1a could be 
isolated in good yield, but both components were 
characterized by X-ray crystallography. Figure 2 
provides views of compounds 1a and 1b. 
 
Figure 2. Views of complexes 1a and 1b with atom numbering 
schemes. Ellipsoids are drawn at the 30% probability level. 
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Due to the asymmetry of the cytosine ligands both 
complexes are chiral. Salient structural features (for 
more data, see Table S1 in the Supporting Information) 
are as follows: Pt1–N3, 2.047(4) Å (1a), 2.034(5) Å (1b); 
Pt1–N11(NH3), 2.030(5) Å (1a), 2.004(6) Å (1b); Pt1–Cl1, 
2.3027(14) Å (1a), 2.3134(18) Å (1b); Pt1–Cl2, 
2.2899(12) Å (1a), 2.2933(16) Å (1b); dihedral angle 
cytosine plane/Pt plane, 66.83(11)° (1a), 76.80(14)° 
(1b). As can be seen, there is a trend that Pt1–Cl1 
bonds, hence those trans to NH3 are longer than the 
Pt1–Cl2 bonds, and at least for 1a, this difference is 
significant (9σ), consistent with findings for the 2-
picoline and 3-picoline analogues.
[6]
 It suggests a higher 
trans influence of NH3 over the N3-bound cytosine 
nucleobase. 
 
Diaqua species of compound 1a 
Types of condensation patterns 
Treatment of compound 1a with two equivalents of an 
Ag
+
 salt in water yields cis-[Pt(H2O)2(NH3)(1-MeC-N3)]
2+
 
(2). The resulting solution is strongly acidic (in D2O, pD 
1–2) as a consequence of the acidity of the aqua 
ligands and formation of N3,N4-bridged dinuclear 
species, which likewise leads to a release of protons 
from the exocyclic amino group of the 1-MeC ligand. A 
1
H NMR spectrum recorded after 24 h at RT is given in 
Figure 3. Typically, 20 % of the diaqua species has been 
converted under these conditions to a dinuclear 
[{Pt(D2O)(NH3)(1-MeC
–
-N3,N4)}2]
2+
 species with its 
chemical shifts at δ = 6.85 (H6), 5.99 (H5) and 3.29 
(CH3) ppm (marked with an * in Figure 3). The chemical 
shifts of the newly formed product are close to values 
previously seen with head-tail dimers of the 
composition cis-[{Pt(NH3)2(1-MeC
–
-N3,N4)}2]
2+
, and 
characteristically upfield shifted from those of 
compounds 1a and 2 with N3 platinated neutral 1-
MeC.
[12a]
 
 
Figure 3. 1H NMR spectrum (200 MHz) of cis-[Pt(H2O)2(NH3)(1-MeC-
N3)]2+ (2) prepared from compound 1a and two equivalents of AgNO3 
in D2O, RT, 24 h after addition of AgNO3, with cPt = 0.02 mol/L. Signals 
with asterisks refer to N3,N4-bridged species [{Pt(D2O)(NH3)(1-MeC
–-
N3,N4)}2]
2+ (see main text). The pD of the solution has dropped to 
1.85. 
When kept at low pD values (1–2) in D2O, samples 
of compound 2 undergo isotope exchange of the 
proton at the C5 position, giving rise to pseudo-triplets 
of the H6 resonances and a decline of the original H5 
doublets (Figures S1 and S2 in the Supporting 
Information). Readjustment of the pD of the sample to 
values between 5 and 7 leads mainly to multiple new 
H5 and H6 doublets around δ = 5.8 and 7.5 ppm, yet 
also to new weak doublets in the vicinity of the 
resonances of the initial condensation product marked 
with asterisks (Figure 4, bottom spectrum, and Figure 
S3 in the Supporting Information). 
As a consequence of the existence of two non-
equivalent aqua ligands in compound 2 (Scheme 1), 
and their expected differences in acidities (see below), 
there are different possibilities how monomeric 
compounds 2a and 2a' can self-condense to give the 
head–tail dinuclear complexes 3a, 3a', and 3a'', 
respectively. Compound 3a is achiral, but the two other 
dimers are chiral, which, if formed, occur as pairs of 
enantiomers. 
Given the closeness in chemical shifts marked with 
asterisks, there is a good chance that these minor sets 
are due to any of the other head-tail dimers. From a 
steric point of view (interference of parallel NH3 and 
OH2 ligands), the mutual trans arrangement of the 
bridging 1-methylcytosinato ligands in compounds 3a 
and 3a' may be less favorable than the cis arrangement 
in compound 3a'', however.
[12b]
 For an alternative 
assignment see also below. 
 
Figure 4. 1H NMR spectra (D2O, 400 MHz) of compound 2 adjusted to 
different pD values, that is, pD 5.25 (bottom) and pD 6.45 (top). In 
both cases, the pD value drops within 12 h at RT to approximately 4.1 
(5.1). The diaqua species 2 has its 1-MeC resonances unchanged, 
whereas compounds 2a and 2b have undergone condensation 
reactions to µ-OH species. Signals of the most intense other 
condensation product with N3,N4 bridge formation (compare Figure 
3) are marked by asterisks. Note that there are additional doublets of 
low intensities close those resonances. 
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Scheme 1. Acid-base equilibria of compound 2 and feasible dinuclear 
C– condensation products. Compounds 3a' and 3a'' are chiral and 
exist as pairs of enantiomers. A feasible condensation product 
between compounds 2a and 2a' is not shown (see text). 
From model building it is possible to construct yet 
another head–tail dimer, formed between compounds 
2a and 2a' and assuming that condensation reactions 
involve again the Pt–OH groups (not shown in Scheme 
1). This dinuclear product is likewise chiral, has the 
bridging cytosinato ligands cis at one Pt and trans at 
the other and should give two 1-MeC
–
 sets of equal 
intensities. 
Concerning the acidities of the two non-equivalent 
aqua ligands of compound 2, it can be expected that 
there exist four different pKa values, which, however, 
are probably pairwise very similar, hence pKa1 ≃ pKa2 
and pKa3 ≃ pKa4. 
Although the aqua ligand trans to 1-MeC can be 
expected to be slightly more acidic than the one trans 
to the NH3 ligand,
[8b]
 differences in pKa values of the 
two species 2a and 2a' cannot be expected to be 
readily seen in the 
1
H NMR spectra, as they represent 
tautomers.
[13]
 The pD value dependent 
1
H NMR spectra 
of compound 2 in the range 1.8–8.0 reveal the 
following: The 1-MeC resonances of compound 2 (i.e., 
species 2a and 2a') display virtually no pD value 
dependence in the range mentioned. For this reason, 
pKa values of the aqua ligands of compound 2 (i.e., 
species 2a and 2a'), expected to be in the order of 5–
7,
[14]
 could not be deduced by NMR spectroscopy. The 
reason for this unexpected behavior is obviously the 
rapid conversion of mononuclear hydroxo species 
between the time of pD adjustment and spectra 
recording. Consistent with this view, resonances of 
compound 2 only drop in intensities as the pD is raised, 
whereas at the same time 1-MeC resonances of the 
newly formed complexes grow in, at chemical shifts 
slightly upfield from those of compound 2 (Figure 4). 
This finding strongly suggests that Pt coordination 
in the derivatives occurs still through the N3 atom of 
the 1-MeC ligand, hence that µ-OH condensation 
products are formed, similar to the situation with cis-
[Pt(NH3)(H2O)(OH)]
+
.
[15]
 Given the various possible ways 
of condensation of compounds 2a and 2a' (homo- or 
hetero-condensation, single OH
–
 bridges or cyclic 
oligomers, compare compounds 4a–4e in Scheme 2), it 
is not possible to individually assign the various signals 
seen in the 
1
H NMR spectra. Analogous µ-OH species 
seem not to be observed with 2- and 3-picoline 
complexes cis-[Pt(H2O)2(NH3)(pic)]
2+
,
[6]
 at least not at a 
fourfold lower concentration (5 mM). In contrast, 
compound 2 undergoes µ-OH condensation, even at a 
concentration of 5 mM, with the corresponding 
resonances seen quickly after pD adjustment. 
 
Scheme 2. Feasible condensation reactions of compounds 2a, 2a' 
leading to the dinuclear µ-OH species 4a–4e. In analogy to cis-
[Pta2(H2O)(OH)]
+ also tri-and tetranuclear µ-OH species are feasible. 
There is a third possibility by which condensation 
reactions can occur involving a ligand deprotonation 
process, namely µ-NH2 bridge formation. Although less 
unexpected for Pt complexes with oxidation states +III 
and +IV,
[16]
 µ-NH2 complexes are also known for 
diplatinum(II) species isolated from aqueous 
solution,
[17]
 including 1-MeC-containing 
compounds.
[18,19]
 
All three mentioned condensation reactions leading 
to µ-OH, µ-NH2, or µ-1-MeC
–
 species require 
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deprotonation of ligands (H2O, NH3, or 1-MeC, 
respectively). There exists, however, also the possibility 
that condensation does not involve loss of protons, 
namely if bridge formation is through the N3 and O2 
atoms of the neutral 1-MeC ligand, with only water 
ligands being replaced. Indeed, X-ray crystal structures 
are available for such N3,O2 binding patterns in 
complexes of Ag
+
,
[20a]
 Zn
2+
,
[20b]
 and heteronuclear 
complexes containing Pt
2+
 at the N3 position and a 
second transition metal ion at the O2 position.
[20c,20d]
 
From a structural point of view, dinuclear complexes 
should be analogous to compounds 3a, 3a', and 3a'' 
(with the N4 atom being replaced by the O2 atom), but 
there is a question whether the O2(1-MeC) bond to Pt 
is inert or labile in aqueous solution. We tend to 
believe that the latter is the case and, therefore, do not 
further discuss the option of N3,O2 bridge formation 
here. In any case, the experimental observations of a 
drop in the pH value following preparation of the 
diaqua complex 2 is inconsistent with N3,O2-bridge 
formation being a dominant reaction. 
Finally, there may be an additional complication in 
the behavior of compound 2 (i.e., species 2a and 2a'), 
namely the possibility of Pt
II
 migration from the N3 
position to the exocyclic N4 position. Resonances of the 
Pt(1-MeC-N4) species can be spread over a 
considerable shift range,
[21]
 and some of the very weak 
H5,H6 doublets seen in the bottom spectrum of Figure 
4 in fact may be due to such compounds.
[22]
 
Unfortunately the quality of signal-to-noise ratio of 
1
H 
NMR spectra recorded at higher pD values (i.e., pD 7–8) 
is decreasing, and these minor resonances are no 
longer observable. 
 
Partial oxidation 
The disappearance of resonances due to N3,N4-bridged 
1-MeC
–
 species in the 
1
H-NMR spectra may be a 
consequence of the formation of paramagnetic, 
partially oxidized mixed-valence Pt compounds. 
Samples of aqueous solutions of compound 2 become 
greenish within 20 h (max. absorption at λ = 607 nm), 
with a continuous increase in color and intensity and a 
shift of the major absorption towards higher 
wavenumbers (λ = 634 nm). At the same time a second 
absorption near λ = 442 nm grows (Figure S4 in the 
Supporting Information). Concentration dependent 
UV/Vis spectra reveal an essentially linear relationship 
with the two bands in the concentration range 0.2–2.0 
µmol/mL of Pt. Extinction coefficients could not be 
determined, as the concentration of the colored 
species is unknown. We contribute at least the 
absorption above λ = 600 nm to an intervalence 
charge-transfer (CT) band, similar to the situation with 
other “platinum pyrimidine blues”.
[23]
 The mixed 
valence of species in aged samples of compound 2 is 
qualitatively confirmed by EPR spectroscopy (Figure S5 
in the Supporting Information) of frozen aqueous 
solutions. The EPR spectra are similar to previously 
reported ones, suggesting axially interacting Pt
II
 and Pt
III
 
centers.
[24]
 As compared to a published spectrum of a 
Pt
II
/Pt
III
 complex of cis-(NH3)2Pt and cytidine,
[24b]
 the 
spectral lines are considerably broader in our case, 
possibly suggesting a higher degree of Pt oxidation 
and/or the presence of different, albeit structurally 
similar paramagnetic species. 
Figure 5 shows ESI mass spectra of cis-
[Pt(H2O)2(NH3)(1-MeC-N3)](NO3)2 recorded after 1d 
and after 3d (cPt = 0.02 M). Different target masses 
were applied while recording the spectra, causing 
changes in relative intensities of peaks and hence in the 
overall appearance of the spectra. Nevertheless, a 
detailed look reveals the appearance of new signals 
with time and in addition time dependent changes of 
individual signals. 
 
Mass spectra of compound 2 and its condensation and 
oxidation products 
As pointed out above, the diaqua species cis-
[Pt(H2O)2(NH3)(1-MeC-N3)]
2+
 (2) undergoes 
preferentially two types of condensation reactions in 
water, involving at low pH preferably the 1-MeC 
ligands, and at weakly acidic to neutral pH the OH2/OH 
ligands. In the first case, 1-MeC
–
-N3,N4 bridged species 
are subject to facile oxidation in the presence of air 
(see above) leading to deeply colored mixed-valence Pt 
compounds initially. In the following we describe 
results obtained from ESI mass spectra of compound 2 
at different time intervals. We were hoping to get a 
deeper insight into the species present in solution, 
even though we were aware that no real 
complementarity exists between this method and 
1
H 
NMR spectroscopy,
[25]
 in that essentially only +1 cations 
are detected under the conditions of ESI MS, and that 
the distribution of species present in solution is not 
reflected by relative intensities of the peaks in the mass 
spectra. Finally, the uncertainty concerning 
fragmentation or association processes in the gas 
phase poses further questions. 
Figure 5 shows ESI mass spectra of cis-
[Pt(H2O)2(NH3)(1-MeC-N3)](NO3)2 recorded after one 
day and after three days (cPt = 0.02 M). Different target 
masses were applied while recording the spectra, 
causing changes in relative intensities of the peaks and 
hence in the overall appearance of the spectra. 
Nevertheless, a detailed look reveals the appearance of 
new signals with time and in addition time-dependent 
changes of individual signals. 
Aged samples of compound 2 (see, e.g., Figure 5, 
bottom) reveal characteristic “families” of signals, 
centered around m/z = 1650, 1350, 1024, and 706. 
Clearly these “families” represent species of different 
stoichiometries (Pt/1-MeC/1-MeC
–
) as outlined below. 
Within a “family” signals differ typically by Δm = 17 or 
18, suggesting differences in NH3 and H2O contents. 
Each signal itself reveals characteristic isotopic 
patterns. With very few exceptions, the spacing 
between these fine structure lines is one nominal mass 
unit, indicating +1 charges for most ions. 
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Figure 5. ESI mass spectra of aqueous solution of compound 2 after 
a) one day (target mass = 708) and b) three days (target mass = 
1065). The complex concentration was 0.02 M. Note: To improve the 
ion storage in different mass regions, different target mass 
parameters were applied. 
There is a general problem of assigning the 
individual signal groups to particular structures of the 
Pt complexes for the following reasons: 1) Complexes 
may exist in different tautomeric forms or even in 
equilibria of tautomers. For example, a dinuclear 
complex could have a µ-OH
–
 bridge and a terminal NH3 
ligand or alternatively a µ-NH2
–
 bridge and a terminal 
H2O ligand. The sum of the two charges is identical in 
both cases. Similarly, the combinations of OH
–
 and 1-
MeC or of H2O and 1-MeC
–
 are identical. 2) The almost 
identical masses of NH3 and OH
–
 permit a 
differentiation in high resolution mass spectrometry 
only. This feature can cause an ambiguity regarding 
relevant Pt oxidation states as well, in that 
combinations of Pt
II
–NH3 and Pt
III
–OH
–
 would be 
difficult to differentiate. From a coordination chemistry 
point of view, the conversion of a Pt
II
–NH3 moiety to a 
Pt
III
–OH
–
 would definitely be reasonable, considering 
the fact that any Pt
III
–NH3 bond of the d
7
 metal ion can 
be expected to be much more labile than of the d
8
 
metal ion Pt
II
. Consequently, a reaction of type [Pt
III
–
NH3]
n+
 + H2O → [Pt
III
–OH]
(n-1)+
 + NH4
+
 is a realistic 
option, even in solution.
[12,26]
 3) When working with the 
nitrate salt of compound 2, there is the additional 
problem of differentiating the almost identical masses 
of 1-MeC
–
 (m = 124) and two NO3
–
 anions (m = 2 × 62 = 
124). Of course, this ambiguity can be circumvented by 
use of a different counterion, for example ClO4
–
 or BF4
–
 
instead of NO3
–
. 
A typical mass spectrum of cis-[Pt(H2O)2(NH3)(1-
MeC-N3)](NO3)2, 24 h after mixing cis-[PtCl2(NH3)(1-
MeC-N3)] with AgNO3 in water (cPt = 0.02 M; pH = 1.9 
after 24 h; the color of solution is light green) reveals 
signals due to mononuclear complexes centered at m/z 
= 372, 354, and 336. They correspond to [Pt(OH
–
)(H2O)(NH3)(1-MeC-N3)]
+
 as well as species containing 
chelating 1-MeC (N3,O2)
[27]
 or chelating 1-MeC
–
 
(N3,N4) ligands
[28]
 (Scheme S1 in the Supporting 
Information). 
The cluster of signals between m/z = 761 and 655, 
which has its most intense peaks at m/z = 707 and 725, 
corresponds to a group of dinuclear Pt complexes. 
There is a large variety of possible structures for this 
“family”, as outlined in Schemes 3 and 4, depending on 
the bridging ligands, 1-MeC
–
 or OH
–
. Figure 6 gives an 
 
 
Scheme 3. Suggested structures for complexes of m/z = 743 to 707 
formed by loss of H2O either through condensation reactions or 
through the loss of originally bonded aqua ligands. 
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enlargement of the experimental signal centered at 
m/z = 707 and a simulated spectrum for [Pt2(1-MeC
–
-
N3,N4)2(OH
–
)(NH3)2(H2O)]
+
. Despite the generally good 
agreement between the two spectra, there is the 
question (see intensities of the m/z = 704 signal) 
whether the experimental spectrum represents in fact 
the superposition of m/z = 707 and a small fraction of a 
species centered at m/z = 706, hence of [Pt
II
Pt
III
(1-MeC
–
-N3,N4)2(NH3)2(OH)2]
+
 (see also the section on the mass 
spectrometric results of compound 7). 
 
Scheme 4. Suggested structures for complexes of m/z = 707 to 655 
formed by the loss of H2O or NH3, with different bridging modes of 
the PtII centers. 
 
Figure 6. Fine structure of the m/z = 707 ESI-MS peak after a reaction 
time of one day (top) and simulated spectrum for [Pt2(1-MeC
–-
N3,N4)2(OH
–)(NH3)2(H2O)]
+ (bottom). The signal at m/z = 704 suggests 
a superposition with a minor species centered at m/z = 706 which is 
consistent with observations in aged solutions. 
The “family” just discussed is partially overlapping 
with another one with maxima at m/z = 770, 752, 734, 
and 717. These species can be assigned to 
diplatinum(II) complexes containing coordinated 
and/or electrostatically bonded NO3
–
 ions (Scheme S2, 
Supporting Information). This interpretation seems 
reasonable considering the fact that this set of signals 
is not observed when the diaqua species 2 is applied as 
its BF4
–
 salt. 
Ageing of the diaqua species 2 (3 d, RT) leads to 
new signals, the characteristics of which are as follows: 
Firstly, tri- and tetranuclear Pt complexes form, 
centered at around m/z = 1024 and 1350. There is even 
a group of peaks centered at m/z = 1650, which, 
however, is too low in intensity to be discussed here. It 
would, logically, correspond to a pentanuclear Pt 
species. Secondly, the signals due to dinuclear 
complexes undergo shifts to lower m/z values with 
time. Regarding the second case, the signal with a 
maximum at m/z = 707 shifts to have its maximum at 
m/z = 706 after three days. This feature is consistent 
with a mixture of two singly charged cations being 
present in the sample, which differ by a mass of one 
(Figure 7). 
A similar shift occurs for the peaks at m/z = 689 
(shift to 688) and m/z 672 (shift of maximum to m/z = 
671). The most logical interpretation of this loss of one 
mass unit and simultaneous maintenance of charge is a 
substitution of a Pt
II
–H2O entity by a Pt
III
–OH unit. In 
fact, an increase in Pt oxidation state is expected to 
cause a drop in pKa of any coordinated ligand, including 
water. Alternatively, this process can be seen as a 
proton-coupled electron transfer reaction, namely 
formally: 2 [X–Pt
II
–OH2]
+
 + ½ O2 → 2 [X–Pt
III
–OH]
+
 + H2O 
(with X = ligand with negative charge; other ligands 
omitted). As far as dinuclear species are concerned, this 
implies the formation of mixed valence Pt
II
/Pt
III
 species. 
Possible structures are formulated in Scheme 5. 
 
Figure 7. ESI mass spectra of compound 2: Fine structure for the 
signal at m/z = 706 after 3 d (top) with simulated spectra for [Pt2(1-
MeC–-N3,N4)2(OH
–)(NH3)2(H2O)]
+ (m/z = 706; middle) and [Pt2(1-MeC
–
-N3,N4)2(OH
–)2(NH3)2]
+ (m/z = 707).(below). 
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Scheme 5. Proposed structures for mixed valence complexes of m/z = 
706 to 671 formed by loss of H2O or NH3. Alternative tautomeric 
forms are not included. 
Yet another “family” of MS peaks, occurring 
between m/z = 832 and 762, is identified, which 
corresponds to complexes of a Pt2L3 (L = 1-MeC or 1-
MeC
–
) stoichiometry. The number of possible 
structures and combinations of Pt oxidation states 
becomes increasingly larger for these peaks (Scheme S3 
in the Supporting Information). 
Trinuclear Pt complexes of a stoichiometry of Pt3L3 
give rise to a cluster of intense peaks in the range m/z 
1000–1100. The number of feasible structures, either 
linear or cyclic, increases tremendously, as does the 
combination of possible Pt oxidation states (Scheme S4 
in the Supporting Information). It suffices to state that 
there is precedence for the existence of cyclic, 1-MeC
–
 
bridged trimeric complexes of analogous Pd
II[29]
 and Pt
II
 
complexes,
[30]
 and of mixed OH
–
, 1-MeC
–
 bridged 
species,
[31]
 among others. Consequently, it can be 
concluded that the proposals made are chemically 
realistic. Likewise, formation of such species (cyclic or 
linear) from the initial monomer [Pt(OH)(H2O)(NH3)(1-
MeC-N3)]
+
 is readily rationalized (Scheme S5 in the 
Supporting Information). Again, by applying the 
replacement of Pt
II
–H2O by Pt
III
–OH
–
 partially oxidized 
Pt complexes can be postulated, as shown in Figure 8 
for species for the signal at m/z = 1077. 
As a final group of signals, we shall examine those 
related to tetranuclear Pt4L4 complexes of aged 
samples. This family of peaks occurs above m/z = 1300. 
Again, there are numerous feasible structures, which 
could account for the masses experimentally observed, 
which include cyclic as well as open-chain structures  
 
 
Figure 8. Different feasible structures for mixed-valence complexes 
with m/z = 1077, either in linear or cyclic arrangements. 
with simultaneous 1-MeC
–
, OH
–
, and/or NH2
–
 bridge 
formation. Thus far, we have not discussed the feature 
of mixed 1-MeC
–
, OH
–
, NH2
–
 bridging in detail yet, but it 
must be pointed out that there is structural evidence 
for the existence of curved Pt2M2 (M = Pd
[18]
 or Pt
[19]
) 
skeletons with all of the three mentioned bridges 
present in a single complex. Feasible structures of [Pt
II
]4 
species displaying this feature are shown in Scheme 6. 
It should be noted that the experimentally observed 
mass spectra reveal the above-discussed shifts to lower 
masses, hence the existence of partially oxidized 
complexes. Figure 9 compares the MS peaks centered 
at around m/z = 1395 and a simulated spectrum of a 
tetranuclear complex of the composition [Pt4(1-MeC
–
)2(1-MeC)2(NH3)2(NH2
–
)(OH
–
)2]
+
 (m/z = 1395.18). The 
experiment clearly reveals a superimposition with one 
or more species of lower mass, for example, m/z = 
1394 and/or 1393. 
 
Figure 9. ESI-MS peak m/z = 1395 (top) with simulation for [Pt4(1-
MeC–-N3,N4)2(1-MeC-N3)2(OH
–)3(NH3)2(NH2
–)2]
+ (bottom). The Pt 
concentration was 0.02 M, target mass was 1065. The observed 
peaks indicate superimposition with species of lower m/z such as 
1394 and/or 1393. 
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Scheme 6. Proposed decomposition processes based on a 
tetranuclear species with m/z = 1413 involving loss of H2O and NH3 
respectively, leading eventually to a fragment with m/z = 1325. 
Models of potential DNA adducts of 1a with guanine 
targets 
Assuming that the activity of compound 1a in tumor 
models (see below) is a consequence of DNA binding, 
and assuming further that the guanine-N7 sites are 
preferred binding sites of compound 1a as in the case 
of cisplatin, a reaction scheme is possible which leads 
to three products (Scheme 7), that is, SP-4-4-[PtCl(NH3) 
(1-MeC-N3)(G-N7)]
+
, SP-4-2-[PtCl(NH3)(1-MeC-N3)(G-
N7)]
+
 and cis-[Pt(NH3)(1-MeC-N3)(G-N7)2]
2+
 (with SP = 
square-planar, and G = guanine base in double-
stranded (ds)-DNA).
[32]
 In principle, all three products 
can occur as multiple stereoisomers if rotation around 
the Pt–N(nucleobase) bonds is hindered and 
consequently different mutual orientations of the two 
or three heterocyclic rings can exist.
[33]
 
 
Scheme 7. Possible pathways for the formation of cis-[Pt(NH3)(1-
MeC-N3)(G-N7)2]
2+ (with G = guanine base in ds-DNA) from 
compound 1a through SP-4-4-[PtCl(NH3)(1-MeC-N3)(G-N7)]
+ and 
through SP-4-2-[PtCl(NH3)(1-MeC-N3)(G-N7)]
+. 
The scheme reveals that compound 1a not only can 
behave like cisplatin, hence can form G,G intrastrand 
adducts (end product), but also monodentate DNA 
adducts (SP-4-4 and SP-4-2) are feasible, in which the 1-
MeC ligand of compound 1a is located in the major 
groove of DNA, similar to the situation observed for 
binding of monofunctional cis-[Pt(NH3)2(py)Cl]
+
 (py = 
differently substituted pyridines) to ds-DNA.
[7]
 Clearly, 
the stereochemical situation is different for the SP-4-4 
and SP-4-2 adducts, but any polymerase activity might 
be seriously affected by either adduct. With the end 
product cis-[Pt(NH3)(1-MeC-N3)(G-N7)2]
2+
 the well-
established kinking of DNA
[34]
 is to be expected, hence 
one might speculate on a synergy of two effects 
regarding the proper function of DNA. For picoplatin, 
Sadler et. al. have prepared and structurally 
characterized a model of the corresponding end 
product cis-[Pt(NH3)(picoline)(G-N7)2]
2+
.
[35]
 In the solid 
state, the two guanine bases, both bonded to Pt via N7 
sites, adopt a head-tail orientation, with their H8 
resonances practically indistinguishable in neutral to 
weakly acidic aqueous medium. In any case, only a 
preferred stereoisomer, yet not a complicated mixture, 
is present in solution. 
Starting out from compound 1a, we decided to 
learn more about the sequence of steps leading to cis-
[Pt(NH3)(1-MeC-N3)(G-N7)2]
2+
 by reacting the 
dichloride complex 1a with 9-EtGH (9-ethylguanine) as 
a model for a guanine base in ds-DNA. Figure 10 gives 
representative 
1
H NMR spectra of mixtures of 
compound 1a with 9-EtGH (1:1 and 1:2) after different 
reaction times in D2O, pD ≈ 6, at room temperature. 
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Figure 10. 1H NMR spectra (300 MHz) of the reaction of compound 1a 
with one equivalent of 9-EtGH at RT in D2O after 24 h, 48 h, 3 d, 8d 
(bottom to second from top), and two equivalents 9-EtGH after 3 d 
(top, pD 6). Detail of the shift range of heteroaromatic protons. (o = 
SP-4-4-[PtCl(NH3)(1-MeC-N3)(9-EtGH-N7)]
+, * = SP-4-2-[PtCl(NH3)(1-
MeC-N3)(9-EtGH-N7)]+, x = cis-[PtCl2(NH3)(1-MeC-N3)] (1a) + = cis-
[Pt(NH3)(1-MeC-N3)(9-EtGH-N7)2]
2+, ◊ = free 9-EtGH). 
The first product to be detected in the 
1
H NMR 
spectrum is assigned to SP-4-4-[PtCl(NH3)(1-MeC-N3)(9-
EtGH-N7)]
+
, hence to a species in which 1-MeC-N3 and 
9-EtGH-N7 are oriented trans to each other. The 
arguments are as follows: First, the Cl ligand trans to 1-
MeC in compound 1a is expected to hydrolyze faster 
than the Cl ligand cis to the 1-MeC ligand, as steric bulk 
of the two exocyclic groups of 1-MeC (O2 and N4H2) in 
the trigonal-bipyramidal (tbp) transition state is 
expected to slow down substitution kinetics of the 
chlorido ligand cis to the 1-MeC ligand by water. 
Second, the chemical shift of the H8 resonance of the 
9-EtGH ligand of the first product formed (δ = 8.37 
ppm) compares favorably well with that in trans-
[Pt(NH3)2(1-MeC-N3)(9-EtGH-N7)]
2+
,
[36]
 whereas in the 
corresponding cis isomer, this resonance occurs at 
higher field, δ = 8.18 ppm
[37]
 as a consequence of the π-
stacking effect of the 1-MeC ligand. 
At a later stage, three more H8 resonances of 
coordinated 9-EtGH ligands are observed: A weak 
singlet at δ = 8.17 ppm, assigned to SP-4-2-
[PtCl(NH3)(1-MeC-N3)(9-EtGH-N7)]
+
 and consistent with 
a slower hydrolysis rate of the Cl ligand cis to the 1-
MeC ligand, as well as two singlets of equal intensities 
at δ = 8.28 and 8.29 ppm. The latter resonances are 
assigned to the two non-equivalent 9-EtGH ligands in 
the end product cis-[Pt(NH3)(1-MeC-N3)(9-EtGH-
N7)2]
2+
. 
When compound 1a and 9-EtGH are reacted in a 1:2 
ratio under otherwise similar conditions of pH and 
temperature, the bis(9-ethylguanine) product is the 
dominant species after sixteen days. In the absence of 
X-ray structural evidence no firm conclusions regarding 
the relative orientations of 9-EtGH and 1-MeC ligands 
in cis-[Pt(NH3)(1-MeC-N3)(9-EtGH-N7)2]
2+
 are possible. 
Given the sharpness of the guanine resonances of all 
the products and considering the steric congestion 
around the central metal caused by the three 
coordinated nucleobases, we tend to favor a situation 
without fast nucleobase rotation, however. An isomer 
of the end product, trans-[Pt(NH3)(1-MeC-N3)(9-EtGH-
N7)2]
2+
, obtained by reaction of trans-[Pt(H2O)2(NH3)(1-
MeC-N3)]
2+
 with 9-EtGH, has earlier been reported by 
us.
[38]
 
 
trans-[PtX2(NH3)(1-MeC-N3)] [X = I (5a), Br (5b)] 
We have previously described the synthesis of the trans 
isomer of compound 1a, trans-[PtCl2(NH3)(1-MeC-N3)], 
and its X-ray crystal structure,
[39]
 as well as the 
synthesis of trans-[PtI2(NH3)(1-MeC-N3)] (5).
[9]
 We have 
now obtained 5 in a slightly modified way (compare to 
Experimental Section) and furthermore a DMF adduct 
of 5, trans-[PtI2(NH3)(1-MeC-N3)]·DMF (5a), the crystal 
structure of which was determined. Starting from 5, 
the bromide analogue trans-[PtBr2(NH3)(1-MeC-N3)] 
(5b) was also prepared and isolated as single crystals 
suitable for X-ray crystallography. Like its chlorido 
analogue, compound 5 has been proven a useful 
precursor for the synthesis of tris(nucleobase) 
complexes derived from an original cis-(NH3)2Pt
II
 
entity,
[11]
 for square-planar Pt complexes with up to 
four different ligands,
[40]
 as well as for 1-MeC
–
 bridged 
diplatinum(III) species.
[9]
 
Figure 11 shows the structures of compounds 5a 
and 5b. As expected, the 1-MeC planes form large 
dihedral angles in 5a (82.04(15)°) and 5b (74.9(2)°), and 
the iodido ligands are somewhat bent away from the 1-
MeC plane, resulting in a smaller I–Pt–I angle than the 
ideal 180°, namely 173.972(18)°. For compound 5b, this 
effect is less pronounced (178.88(4)°). Otherwise there 
are no unexpected structural features to be seen (Table 
S2 in the Supporting Information). 
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Figure 11. Views of complexes 5a and 5b with atom numbering 
schemes. Ellipsoids are drawn at the 30% probability level. 
 
Solution behavior of compound 5a and of its diaqua 
species 6 
Compound 5 and 5a are poorly soluble in water. 
Compound 5 and 5a are well soluble in DMF, however 
(Figure S6 in the Supporting Information). Removal of 
the iodido ligands of either compound by using AgNO3 
in D2O yields trans-[Pt(D2O)2(NH3)(1-MeC-N3)]
2+
 (6), 
which is subject to rapid condensation, accompanied 
by a drop in the pD value, partial oxidation of Pt and 
development of an intensive purple color (λmax = 516 
and 630 nm). The EPR signal of a frozen solution is 
characteristic of a mixed-valence species as previously 
reported.
[9]
 For MS studies with compound 6 (non-
deuterated), see below. According to 
1
H NMR 
spectroscopy and the X-ray structure of a 
diplatinum(III) derivative,
[9]
 the primary condensation 
product at low pH is the head–tail dinuclear complex 7 
(Scheme 8). As the two aqua/hydroxido ligands in 
compound 7 are equivalent, condensation reactions 
between OH groups and N4H2 sites of the 1-MeC ligand 
lead to a single product 7, unlike in the case of 
compounds 2a and 2a'. Like species 3a'', compound 7 is 
also chiral and is formed as a pair of enantiomers. 
 
Scheme 8. Formation of the ht-dimer 7. It is formed as a pair of 
enantiomers. 
As the pD is raised during the ageing process new 
resonances of possibly open µ-OH bridged species can 
be observed in the corresponding 
1
H NMR spectra, 
similar to those shown for the cis-isomer 2. 
 
Isomeric head-tail dimers 3a'' and 7. Comparison with 
compound 8 
Compounds 3a'' and 7 are isomers, which differ in the 
positioning of the NH3 and H2O ligands. These are 
inverted in the two compounds: In compound 7 the 
H2O ligand is trans to the N4 position of the 1-MeC
–
 
ligand. A comparison of the 
1
H NMR chemical shifts of 
the 1-MeC
–
 ligands in compounds 3a'', 7, and that of 
ht-cis-[{Pt(NH3)2(1-MeC-N3,N4)}2]
2+
 (8)
[12a]
 strongly 
suggests closely similar structures for all three 
compounds (Table 1). As head–tail dinuclear structures 
have been established (8) or made highly likely (7), we 
propose an analogous head-tail dinuclear composition 
for the main condensation product of compound 2, 
hence for 3a'' (compare Scheme 1). The minor 
difference in the H5 chemical shift between 
compounds 3a'' and 8 appears to be a consequence of 
the different trans influences of the H2O (in compound 
3a'') and NH3 ligands (in compounds 7 and 8). 
 
Table 1. 1H NMR chemical shifts of dinuclear complexes 3a'', 7, and 8. 
 H6 H5 CH3 
 
6.85 
d; 7.6 Hz 
5.67 
d 
3.29 
s 
 
6.85 
d; 7.3 Hz 
5.76 
d 
3.30 
s 
 
6.88 
d; 7.5 Hz 
5.74 
d 
3.29 
s 
 
Of the three +2 cations, compound 7 is most 
sensitive toward oxidation in air, followed by 
compound 3a'' and finally compound 8. Although 
diplatinum(III) complexes of compound 8 have been 
prepared in several cases by treatment with strong 
oxidants,
[41,42]
 compound 8 retains its faint yellow color 
for a long time in aqueous solutions exposed to air. In 
contrast, aqueous solutions of the diaqua species 7 
become quickly purple (few hours), and aqueous 
solutions of the diaqua species of compound 2 develop 
a green and later a brownish color more slowly (>24 h) 
under comparable conditions of pH and concentration. 
It is obvious that the presence of the good leaving 
group H2O in compounds 3a' and 7 could facilitate 
further condensation reactions beyond the dinuclear 
level, in principle, with involvement of the O2 sites of 
the 1-MeC
–
 bridges. Pt oxidation may be eased in this 
case. It is interesting to note that cis-[PtCl(NH3)2(1-
MeC-N3)]
+
, the precursor of compound 8,
[43]
 likewise 
develops a purple color if allowed to age in solution. A 
partial loss of NH3 and hence the formation of trans-
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[PtCl2(NH3)(1-MeC-N3)] and its hydrolysis product 6, 
respectively, might account for this observation. 
 
Diplatinum(III) derivative of compound 7 
In an attempt to verify the suspected structural 
similarities between compounds 3a'', 7, and 8 (see 
above and Table 1), aqueous solutions containing 
compounds 3a'' and 7, respectively, were treated with 
NH3. It was anticipated that NH3 would replace the 
aqua ligands in compounds 3a'' and 7 to give 
compound 8 in both cases. However, to our surprise, 
1
H 
NMR spectroscopy did not reveal formation of 
compound 8, and neither did X-ray analysis in case of 
compound 7. Rather than substituting the aqua ligand 
in 7, the product isolated revealed that oxidation had 
occurred to a diplatinum(III) complex, h,t-[{Pt(NH3)2 
(OH)(1-MeC
–
-N3,N4)}2](NO3)2·2[NH4](NO3)·2H2O (9), 
with the aqua ligands trans to the N4 position of the 1-
MeC
–
 bridges in compound 7 deprotonated to 
hydoxido ligands and additional ammonia ligands in the 
two axial positions (Scheme 9). 
 
Scheme 9. Reaction of compound 7 with a (a = NH3) in air. 
This finding supports the view concerning the ready 
oxidizability of compound 7. The 
1
H NMR spectrum of 
compound 9 displayed a characteristically downfield 
shifted H6 doublet (J = 7.5 Hz) of 1-MeC
–
 at δ = 7.15 
ppm, whereas the H5 doublet (δ = 5.78 ppm) and the 
CH3 singlet (δ = 3.31 ppm) were less affected by this 
reaction. The 
195
Pt NMR resonance of compound 9 
(D2O, δ = –638 ppm, singlet) was consistent with a 
[Pt
III
]2 structure and the presence of two magnetically 
equivalent Pt centers. The analogous reaction of 
compound 3a'' (present in equilibrium with compound 
2 and µ-OH complexes) with NH3 likewise yielded a 
product with its 1-MeC
–
 resonances at δ = 7.16 (d, J = 
7.5 Hz, H6), 5.77 (d, H5), and 3.31 ppm (s, CH3), which 
appears to be a diplatinum(III) species. 
 
X-ray crystal structure of compound 9 
Figure 12 provides a view of the cation of h,t-
[{Pt(NH3)2(OH)(1-MeC
–
-N3,N4)}2](NO3)2·2[NH4](NO3)·2 
H2O (9) and Table 2 lists selected bond distances and 
angles. Salient structural features are as follows: Both 
metal ions are hexa-coordinated and are connected by 
a short Pt–Pt bond. The bond lengths of 2.5406(6) Å 
makes it the second shortest bond in diplatinum(III) 
complexes containing bridging 1-methylcytosinato 
ligands,
[9,41,42]
 surpassed only by the complex with 
chelating glycinato ligands at either end of the 
dinuclear cation.
[9]
 Apart from the Pt–Pt bond lengths, 
there are several additional differences between 
compound 9 on one hand and the diplatinum(III) 
complexes containing equatorial NH3 or 
ethylenediamine (en) ligands on the other hand. These 
include the rather small tilt angle of 9.1(2)° between 
the PtN3O planes in compound 9, which makes them 
almost parallel, and the rather modest average 
torsional angle of 19.5(3)° about the Pt–Pt bond. In 
complexes containing two NH3 ligands or a chelating en 
ligand in the plane, tilt angles are ca. 20° or larger, and 
torsional angles are likewise larger. It appears that 
intramolecular hydrogen bonding between the OH
–
 
ligand of one Pt plane and the NH3 ligand of the other 
Pt plane (O12···N13, 2.757(7) Å) in compound 9 is 
ultimately responsible for these features of cation 9. Of 
course, there is only repulsion between NH3 or en 
ligands in the other mentioned compounds. The 
geometry of the bridging 1-MeC
–
 ligand is normal. 
Specifically, the C4–N4 bond is short (1.305(7) Å), 
consistent with a pronounced degree of double-bond 
character. The Pt bonded to the N4 atom is forced out 
of the plane of the nucleobase (ring atoms N1 to C6, 
RMSD 0.0382 Å) by –0.581(8) Å, a feature common in 
diplatinum(III) complexes with 1-methylcytosinato 
bridges. 
 
Figure 12. View of cation of compound 9 with atom numbering 
scheme. Ellipsoids are drawn at the 30% probability level. Symmetry 
operation to generate the monomer: –x, y, –0.5–z. 
Table 2. Selected bond lengths (Å), bond angles (°), and angles 
between least-squares planes (°) for compound 9.(a) 
Pt1–Pt1' 2.5406(6) N11–Pt1–Pt1' 176.0(1) 
Pt1–N3' 2.061(5) N13–Pt1–N3' 176.4(2) 
Pt1–N4 1.994(5) N4–Pt1–O12 177.0(2) 
Pt1–O12 2.027(4) N4–Pt1–N13 89.1(2) 
Pt1–N13 2.036(5) N4–Pt1–N3' 91.6(2) 
Pt1–N11 2.184(6) O12–Pt1–N3' 90.2(2) 
O12···N13' 2.757(7) O12–Pt1–N13 89.1(2) 
Pt1N3O / Pt1'N3O 9.1(2) Pt1N3O / 1-MeC 71.7(2) 
(a) Symmetry operation for primed atoms: 1 –x, y, –0.5–z 
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Our initial solution of the crystallographic data of 
compound 9 was that of a compound of the 
composition [{Pt(NH3)3(1-MeC-N3,N4)}2](NO3)4·4H2O, 
which has the identical sum formula as the here used 
one, as supported by the elemental analysis data. It 
was the unreasonably short intramolecular contacts 
between the supposed NH3 ligands of the adjacent Pt 
planes which stirred our doubts, in addition to rather 
low displacement factors compared to the other non-
hydrogen atoms. When replacing one of the NH3 
groups trans to the N4 position of 1-MeC
–
 by OH2, the R 
factor dropped and the displacement factors improved, 
yet an assumed composition of [{Pt(NH3)2(H2O)2(1-
MeC-N3,N4)}2](NO3)4·4H2O was at odds with elemental 
analysis data for N, and common sense tells that a 
diplatinum aqua complex should likely be formed 
under acidic conditions only, at least if the aqua ligand 
is bonded in an equatorial position. Eventually the 
change of a water ligand into a hydroxido ligand, and 
recognition that stoichiometric amounts of ammonium 
nitrate plus sodium hydroxide were applied in the 
synthesis of compound 9 to generate NH3 (in an 
attempt to avoid an excess of ammonia), gave the 
solution used here. This assignment is fully consistent 
with the X-ray data, and the hydrogen atoms of the 
hydroxido ligand, the ammonium cation as well as of 
the additional water of crystallization were located in 
the difference maps and partially even freely refined 
(Figure S7 in the Supporting Information). 
We note that reaction of compound 7 with NH3 
under mild oxidative conditions (presence of air) leads 
to retention of the original Pt coordination spheres, 
that is, with the hydroxido ligand staying trans to the 
N4 atom of the cytosine nucleobases and hence in the 
plane position rather than moving to the axial position. 
The situation thus is similar to that seen in the reaction 
of compound 7 with the amino acid glycine, which also 
yields a diplatinum(III) product with the carboxylate O 
atom bonded in plane and the amino group positioned 
in the apical position.
[9]
 It differs from the situation 
seen in the asymmetrical diplatinum(III) complex h,t-
[(H2O)(en)Pt(1-MeC
–
)2Pt(en)(OH)](ClO4)3,
[42]
 in which 
one of the two en ligands chelates in a mixed 
apical/equatorial fashion, with the hydroxido ligand at 
one of the two Pt ions is trans to the N3 atom of 1-
MeC
–
, however. The water molecule at the second Pt is 
in axial position. 
Complex 7 appears to be an ideal precursor for the 
formation of oligonuclear diplatinum(III) complexes 
held together by single or pairwise µ-NH2 bridges 
following intermolecular condensation reactions 
between equatorial hydroxido and axial NH3 ligands. 
Dimer-of-dimer species of this type, containing four Pt
III
 
centers and two pairs of bridging α-pyrrolidonato
[16b]
 
and acetato
[16c]
 ligands, respectively, have been 
described. In these cases, intermolecular condensation 
between axial hydroxide and equatorial ammonia 
ligands might have led to their formation, hence a 
variation of the above scenario. We note that during 
workup of solutions containing compound 7 we 
occasionally ended up with highly viscous, yellow-
brownish non-crystalline materials, the nature of which 
has not been established, however. 
 
Mass spectra of solutions containing compound 6 
Treatment of trans-[PtI2(NH3)(1-MeC-N3)] (5a) with two 
equivalents of AgNO3 in water produces the 
corresponding diaqua species 6, which, like the 
corresponding cis-isomer 2, undergoes condensation 
and Pt oxidation reactions. Representative ESI mass 
spectra recorded after one and three days of mixing 
compound 5a and AgNO3 (and removal of AgI by 
centrifugation) are provided in Figure S8 in the 
Supporting Information. Compared to the mass spectra 
derived from compound 2 (see above), the following 
similarities and differences were observed: 1) 
Essentially only singly charged cations are seen. 2) The 
ambiguity concerning the composition of individual 
species with regard to tautomerism and possible Pt 
oxidation state remains. 3) Formation of species 
beyond the Pt2L4 level (L = 1-MeC
–
) is not observed with 
compound 5a, or at least very much reduced. 4) The 
tendency of compound 5a to undergo ligand 
disproportionation reactions is very pronounced. For 
example, species of Pt1L3, Pt1L2, Pt2L3, and Pt2L4 
stoichiometries are detected, which are formed either 
in solution or in the gas phase. This finding is in a way 
reminiscent of similar rearrangement reactions of 
bis(1-MeC) complexes of trans-(NH3)2Pt
II
 occurring in 
solution.
[44]
 It implies furthermore the formation of Pt 
species, which no longer carry a nucleobase. 
In the following, we will discuss only several 
selected peak groups in the mass spectra, focussing on 
the question of Pt oxidation states in these species. 
First, signals centered around m/z = 707 shall be 
considered (Figure 13). The experimentally obtained 
spectrum is qualitatively slightly different from that 
obtained with the cis isomer (Figure 6) in that the 
discrepancy in intensities of the m/z = 704 peak is too 
large to be ignored and the signal cannot simply be 
assigned to the head-tail Pt
II
 dimer [Pt
II
2(1-MeC
–
)2(OH
–
)(NH3)2(H2O)]
+
 with m/z = 707. Rather, it is proposed 
that the experimental spectrum represents a 
superposition of m/z = 707 and a partially oxidized 
species with m/z = 706, that is, with [Pt
II
Pt
III
(1-MeC
–
)2(OH
–
)2(NH3)2]
+
. Second, there are signals grouped at 
around m/z = 860. They are indicative of species of a 
stoichiometry of Pt2L3, but the number of signal 
components is too large to assign the experimental 
spectrum to a single compound (Figure 14). Rather, we 
propose that it represents a superposition of several 
(four to five?) sets, ranging from m/z = 858 to 862, for 
example. Possible compositions of four species, 
differing in the protonation states of ligands (1-MeC or 
1-MeC
–
; H2O or OH
–
), the Pt oxidation states ([Pt
II
]2; 
[Pt
II
Pt
III
]; [Pt
III
]2), as well as the NH3 content, are given in 
Scheme 10. 
There is, in principle, an interesting variant possible 
to account for the signals with higher m/z values (i.e., 
861, 862), namely species with Pt oxidation states < 2! 
 
–14– 
A series of species ranging from [(Pt
III
)2(OH)(NH3)(1-
MeC
–
)3(NO3)]
+
 (m/z = 858), [Pt
III
Pt
II
(H2O)(NH3)(1-MeC
–
)3(NO3)]
+
 (m/z = 859), [(Pt
II
)2(H2O)(NH3)(1-MeC
–
)2(1-
MeC)(NO3)]
+
 (m/z = 860), [Pt
II
Pt
I
(H2O)(NH3)(1-MeC
–
)(1-
MeC)2(NO3)]
+
 (m/z = 861), to [(Pt
I
)2(H2O)(NH3)(1-
MeC)3(NO3)]
+
 (m/z = 862), formed formally in 
disproportionation reactions [2 (Pt
II
)2 ⇋ (Pt
III
)2 + (Pt
I
)2] 
and subsequent comproportionations [Pt
III
 + Pt
II
 → 
Pt
III
Pt
II
; Pt
I
 + Pt
II
 → Pt
I
Pt
II
] could account for the 
presence of five species. Although we do not have any 
firm evidence for the existence of mixed Pt
II
Pt
I
 or (Pt
I
)2 
complexes, it should be pointed out that reduction of 
Pt
II
 to Pt
I
 can be achieved under mild conditions in 
solutions containing water and being exposed to air.
[45]
 
Finally, the weak signal set centered around m/z = 925 
is even more complex as it represents a superposition 
of five or even more individual species. The 
stoichiometry of these species is Pt2L4. 
 
Figure 13. ESI mass spectrum of compound 6 in aqueous solution 
(top) with simulations for [Pt2(1-MeC
–-N3,N4)2(OH)2(NH3)2]
+ (middle) 
and [Pt2(1-MeC
–-N3,N4)2(OH)(NH3)2(H2O)]
+ (bottom). The Pt 
concentration was 0.02 M, the target mass was 708. 
 
Figure 14. ESI mass spectrum of compound 8 in aqueous solution 
(top) with simulations for [Pt2(1-MeC
–-N3,N4)3(OH)(NH3)(NO3)]
+, 
[Pt2(1-MeC
–-N3,N4)3(H2O)(NH3)(NO3)]
+, [Pt2(1-MeC
–-N3,N4)2(1-MeC-
N3)(H2O)(NH3)(NO3)]
+, and [Pt2(1-MeC
–-N3,N4)(1-MeC-N3)2(H2O) 
(NH3)(NO3)]
+ (second from top to bottom). The Pt concentration was 
0.02 M, target mass was 708. 
 
Scheme 10. Proposed decomposition processes based on mixed-
valence dinuclear species with m/z = 860 involving loss of single 
protons combined with a change of oxidation states (stepwise 
oxidation) of the Pt centers (a = NH3). 
Cytotoxicity testing 
Compound 1a was tested for antiproliferative activity 
with a crystal violet microtiter assay as described 
previously
[46]
 against a mini-panel of seven human 
cancer cell lines: two lung cancer (LCLC-103H and 
A427), two bladder cancer (5637 and RT-4), one breast 
cancer (MCF-7), one cervix cancer (SISO) and one 
pancreas cancer line (DAN-G). Only in the SISO and 
LCLC-103H lines was appreciable cell growth inhibitory 
activity observed; that is, with IC50 (50% growth 
inhibitory concentration) values of 4.90  0.91 and 
14.90  7.04 µM (mean and standard deviation of three 
independent experiments), respectively. In all other 
lines the IC50 values were greater than 20 µM. Thus, 
compound 1a appears to have selectivity towards 
cervix cancer. In comparison, cisplatin had much lower 
IC50 values in the same seven cell lines, for example, 
with values of 0.24  0.06 and 0.90  0.19 µM for the 
SISO and LCLC-103H cell lines, respectively.
[46]
 
However, the selectivity of cisplatin for the SISO line 
was not as great as that seen with compound 1a. It 
would be interesting to now test compound 1a against 
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a panel of cervix cancer cell lines to confirm this 
selectivity. 
Conclusion 
In the physiological pH range the activated forms of the 
antitumor agent cisplatin, cis-[Pt(NH3)2(H2O)2]
2+
/cis-
[Pt(NH3)2(H2O)(OH)]
+
, undergo self-condensation 
reactions in water to give open and cyclic hydroxido-
bridged oligomers, unless good nucleophiles are 
present. The close analogue, cis-[Pt(H2O)2(NH3)(1-MeC-
N3)]
2+
 (2)/cis-[Pt(H2O)(OH)(1-MeC-N3)]
+
, and likewise 
its isomeric forms trans-[Pt(H2O)2(NH3)(1-MeC-N3)]
2+
 
(6)/trans-[Pt(H2O)(OH)(1-MeC-N3)]
+
, behave 
analogously. However, in addition, condensation 
between a hydroxide ligand and the weakly acidic 
amino group of the cytosine nucleobase is an 
alternative, leading to 1-methylcytosinato (1-MeC
–
-
N3,N4) bridged species. Although not experimentally 
observed in the present study, there is even the 
possibility that an ammonia ligand condenses with a 
hydroxide ligand to give an amido bridge (µ-NH2).
[19]
 All 
three condensation patterns require the loss of protons 
from the original bis(aqua) complex, a feature 
consistent with the observed drop in the pH value 
during the ageing process of the diaqua species 2 and 
6. A fourth feasible condensation pattern, leading to (1-
MeC-N3,O2) bridges, does not involve loss of a proton 
and is suggested not to play a major role in the 
aqueous solution chemistry of compounds 2 and 6, but 
may be realized in solid-state structures of complexes 
isolated from acidic solutions. 
Regarding 1-metylcytosinato bridged complexes, it 
is clear that numerous isomers can be formed in 
principle, yet it appears that dinuclear species with 
head-tail orientation and cis-arrangement of the two 
bases are a preferred motif, not only for derivatives of 
compound 6, for which structural evidence is available, 
but probably also for derivatives of compound 2, 
according to 
1
H NMR spectroscopy. The close vicinity of 
two Pt atoms in these complexes and their orientation 
relative to each other is favorable for redox processes. 
UV/vis and EPR spectra clearly suggest the presence of 
mixed-valence Pt compounds in solution, and the 
isolation of the new diplatinum(III) compound 9, 
obtained without the addition of any oxidizing agent, 
supports this view. 
At the outset of this study it was the hope that by 
use of ESI mass spectrometry a more detailed analysis 
of condensation products present in aged solutions of 
the diaqua complexes 2 and 6 might be obtained. 
However, these expectations have been met with only 
partial success. Although the masses of mono-, di-, tri-, 
and tetranuclear Pt species could be identified, their 
exact composition in most cases proved ambiguous 
due to the possibility of proton exchange between 
different ligands (ligand tautomerism) and the 
coexistence of oxidized metal species. The MS results 
revealed, however, extensive ligand disproportionation 
processes, a feature seen by us occasionally in earlier 
studies.
[44]
 
Experimental Section 
Materials: Cytosine, AgNO3, K2PtCl4, KI, and KBr were of 
commercial origin and used as received. cis-PtCl2(NH3)2,
[47]
 1-
MeC,
[48]
 cis-[PtCl(NH3)2(1-MeC)]Cl
[9]
, trans-PtI2(NH3)(1-MeC-
N3)
[9]
 and NH4[PtCl3(NH3)]
[49]
 were prepared according to 
literature procedures. 9-EtGH and 1-Et-5-MeC were of 
commercial origin (Chemogen, Konstanz). 
Instrumentation: Elemental analysis data were obtained on a 
Leco CHNS-932 instrument. The 
1
H NMR spectra were 
recorded in D2O ([D7]DMF) on Varian Mercury 200 FT-NMR, 
Bruker DPX 300, DRX 400 and DRX 500 spectrometers. 
Chemical shifts D2O are referenced to internal standard 
sodium-3-(trimethylsilyl)-propane-sulfonate TSP (δ = 0.00 
ppm versus tetramethylsilane). 
195
Pt NMR shifts were 
referenced to Na2PtCl6. Spectra recorded in [D7]DMF are 
referenced to the solvent signal at δ = 8.03 ppm. The pD 
values of NMR samples in D2O were measured by using a 
glass electrode and the addition of 0.4 log units to the 
uncorrected value measured (pH*). 
ESI-MS experiments: Aqueous solutions of compounds 1a 
and 5 at a concentration of 0.02 M were treated with two 
equivalents of AgNO3, respectively. The resulting solutions 
were allowed to age at room temperature. After 
centrifugation, the supernatants were analyzed by using ESI-
MS, carried out with an ESI–quadrupole ion trap instrument 
(esquire6000, Bruker) with the following settings: Sample 
flow rate = 4.0 µL/min, nebuliser nitrogen pressure = 689 hPa, 
spray shield voltage = −3500 kV, capillary entrance voltage = 
−4000 kV, nitrogen dry gas temperature = 573 K, dry gas flow 
rate = 5.0 L/min, the helium buffer/collision gas pressure was 
set to 4.0×10
−6
 hPa (the actual pressure in the analyzer was 
approximately 100 times higher). Voltages at the capillary exit 
and lens 2 varied with the change of the target mass. 
Preparations of compounds: 
cis-PtCl2(NH3)(1-MeC-N3) (1a): NH4[Pt(Cl3(NH3)] (200 mg, 
0.565 mmol) and 1-MeC (70.6 mg, 0.565 mmol) were 
dissolved in 4 mL aqueous NaCl solution (cNaCl = 10 M). The 
solution was stirred for 24 h at 40 °C. The light yellow 
precipitate formed by then was filtered and washed with 
water, ethanol, and was subsequently dried at 40 °C. Single 
crystals were obtained from the filtrate kept at 4 °C for four 
weeks. Yield: 153 mg (66%); elemental analysis calcd (%) for 
C5H10N4OCl2Pt : C 14.71, H 2.47, N 13.73; found: C 14.7, H 2.5, 
N 13.8. 
cis-PtCl2(NH3)(1-Et-5-MeC-N3) (1b): NH4[PtCl3(NH3)] (150 mg, 
0.424 mmol) and 1-Et-5-MeC (64.86 mg, 0.424 mmol) were 
dissolved an aqueous solution of NaCl (3 mL, cNaCl = 2.6 M) 
each. The solutions were combined and stirred at 40 °C for 4 
h. After cooling down to RT the solution was kept at 4 °C 
overnight. Few single crystals of compound 1b could be 
isolated and were identified by X-ray analysis. 
trans-PtI2(NH3)(1-MeC-N3) (5): Compound 5 was prepared 
according to a literature procedure.
[9]
 Alternatively, 
compound 5 was obtained by mixing cis-[PtCl(NH3)2(1-MeC-
N3)]Cl (100 mg, 0.235 mmol) with KI (70.78 mg, 0.47 mmol) in 
5 mL of water. The solution was stirred at 40 °C for 3 h and, 
after cooling to RT, kept at 4 °C. Orange needles of compound 
5 formed as a byproduct of cis-[PtI(NH3)2(1-MeC-N3)]I and 
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both products were identified by X-ray analysis (not 
provided). As crystals of the DMF adduct 5a, obtained from 
an NMR sample of compound 5 in DMF solution, proved of 
better quality than those of compound 5, only data of 
compound 5a is reported. The molecular structures of 
compounds 5 and 5a are very similar, however. 
trans-[PtBr2(NH3)(1-MeC-N3)] (5b): A suspension of trans-
PtI2(NH3)(1-MeC-N3) (5) (100 mg, 0.17 mmol) and AgNO3 
(57.48 mg, 0.34 mmol) in water (15 mL) was stirred at RT for 
4 h with light excluded. After filtration of the AgI precipitate, 
KBr (40.27 mg, 0.34 mmol), dissolved in water (1 mL), was 
added to the filtrate. The dark precipitate which formed 
immediately, was filtered off and the filtrate was kept at 4 °C 
for several days until brownish needles of compound 5b 
could be isolated. Yield: 24 mg (27.5 %); elemental analysis 
calcd for C5H12N4O2Br2Pt (monohydrate): C 11.69; H 2.35; N 
10.92; found: C 11.7; H 2.4; N 11.0. 
h,t-[{Pt(NH3)2(OH)(1-MeC
–
-N3,N4)}2](NO3)2·2[NH4](NO3)·2H2O 
(9): trans-PtI2(NH3)(1-MeC-N3) (5) (301 mg, 0.5 mmol) was 
suspended with AgNO3 (169 mg, 1 mmol) in water (20 mL) 
and the solution was stirred at RT for 4 h. AgI was removed 
by centrifugation and the solution was adjusted regularly to 
pH 5 with NaOH for 48 h. NH4NO3 (165 mg, 2.06 mmol) was 
added and the pH value of the solution was adjusted to 
approximately 9.5 with NaOH. After 24 h a precipitate of 
unknown composition was removed by centrifugation. The 
solution was kept under a gentle stream of nitrogen until the 
onset of crystallization and then placed in a refrigerator of 4 
°C. A mixture of NH4NO3 and yellow compound 9 was then 
removed and re-crystallized from water. The yield of 
compound 9 was 41 mg (15 %); elemental analysis calcd for 
C10H38N16O18Pt2: C 11.32; H 3.62; N 21.13; found: C 11.3; H 
3.4; N 20.9. 
Aqua species of 1a and 5: The aqua species of compounds 1a 
and 5 were obtained by mixing either compound 1a (8.6 mg, 
0.02 mmol) or 5 (11.82, 0.02 mmol) with AgNO3 (6.79 mg, 
0.04 mmol) in water (1 mL), or for 
1
H NMR studies in D2O, 
respectively. The suspensions were stirred over night at RT 
with light exclusion. The precipitated silver halides were 
separated by centrifugation. 
X-ray crystallography: Intensity were recorded on an Oxford 
Diffraction Xcalibur S diffractometer (complexes 2a, 2b, 5a 
and 5b), and on an Enraf–Nonius KappaCCD (complex 9) 
diffractometer, both with graphite monochromated Mo Kα 
radiation (λ = 0.71073 Å). Data reduction and cell refinement 
were carried out using the CrysAlisPro software
[50]
 
(complexes 2a, 2b, 5a, 5b), or the DENZO and SCALE-PACK 
software
[51]
 (complex 9). The structures were solved by direct 
or standard Patterson
[52]
 methods and refined by full-matrix 
least-squares methods based on F
2
 by using the SHELXTL 
PLUS, SHELXL-93, SHELXL-97 and WinGX software.
[53]
 The 
positions of heavy atoms were deduced from difference 
Fourier maps and refined anisotropically. In compounds 2a, 
2b, 5a and 5b, protons were included in geometrically 
calculated positions and refined with isotropic displacement 
parameters according to the riding model, whereas in 
compound 9, the hydrogen atoms of the hydroxido ligand as 
well as of the ammonia cation and the water molecule of 
crystallization were located in the difference maps and 
except for the hydroxide hydrogen refined without restraints. 
For the hydroxido ligand the geometry of an idealized OH 
group was assumed with tetrahedral X–O–H angle and a 
rotating group refinement applied (command AFIX 147). ISOR 
restraints were used for the atom C2 in the structure of 
compound 5b. 
Crystal data for cis-PtCl2(NH3)(1-MeC-N3) (1a): 
[C5H10Cl2N4OPt], M = 408.16 g mol
–1
, colorless prisms, 
orthorhombic, space group Fdd2, a = 25.8181(10) Å, b = 
34.3653(12) Å, c = 4.4503(2) Å, V = 3948.5(3) Å
3
, Z = 16, Dcalcd 
= 2.746 g cm
–3
, T = 150(2) K, λ(Mo Kα) = 0.71073 Å, µ = 14.722 
mm
–1
, 13007 reflections collected, 2436 unique (Rint = 
0.0497), R1 [I > 2σ(I)] = 0.0219, wR2 (F, all data) = 0.0396, GoF 
= 1.074. 
Crystal data for cis-PtCl2(NH3)(1-Et-5-MeC-N3)·H2O (1b): 
[C7H16Cl2N4O2Pt], M = 454.23 g mol
–1
, colorless prisms, 
orthorhombic, space group Pbca, a = 7.3380(7) Å, b = 
19.1423(7) Å, c = 19.3797(10) Å, V = 2722.2(3) Å
3
, Z = 8, Dcalcd 
= 2.217 g cm
–3
, T = 150(2) K, λ(Mo Kα) = 0.71073 Å, µ = 10.694 
mm
–1
, 8382 reflections collected, 2998 unique (Rint = 0.0276), 
R1 [I > 2σ(I)] = 0.0289, wR2 (F, all data) = 0.0629, GoF = 0.944. 
Crystal data for trans-[PtI2(NH3)(1-MeC-N3)]·DMF (5a): 
[C8H17I2N5O2Pt], M = 664.16 g mol
–1
, yellow needles, triclinic, 
space group P–1, a = 6.8772(6) Å, b = 8.3733(6) Å, c = 
14.0948(10) Å, α = 75.203(6)°, β = 84.471(6)°, γ = 84.057(6)°, 
V = 778.46(10) Å
3
, Z = 2, Dcalcd = 2.833 g cm
–3
, T = 150(2) K, 
λ(Mo Kα) = 0.71073 Å, µ = 12.981 mm
–1
, 5717 reflections 
collected, 3556 unique (Rint = 0.0347), R1 [I > 2σ(I)] = 0.0319, 
wR2 (F, all data) = 0.0583, GoF = 0.990. 
Crystal data for trans-[PtBr2(NH3)(1-MeC-N3)] (5b): 
[C5H10Br2N4OPt], M = 497.08 g mol
–1
, orange blocks, 
monoclinic, space group P21/c, a = 6.7429(8) Å, b = 
20.2180(19) Å, c = 8.6316(10) Å, β = 110.205(14)°, V = 
1104.3(2) Å
3
, Z = 4, Dcalcd = 2.990 g cm
–3
, T = 150(2) K, λ(Mo 
Kα) = 0.71073 Å, µ = 19.913 mm
–1
, 7654 reflections collected, 
2523 unique (Rint = 0.0571), R1 [I > 2σ(I)] = 0.0350, wR2 (F, all 
data) = 0.0580, GoF = 0.849.  
Crystal data for h,t-[{Pt(NH3)2(OH)(1-MeC
–
-N3,N4)}2](NO3)2 
·2[NH4](NO3)·2H2O (9): [C10H38N16O18Pt2], M = 1060.74 g mol
–
1
, brown blocks, monoclinic, space group C2/c, a = 17.174(3) 
Å, b = 19.440(4) Å, c = 10.551(2) Å, β = 118.51(3)°, V = 
3095.4(10) Å
3
, Z = 4, Dcalcd = 2.276 g cm
–3
, T = 183(2) K, λ(Mo 
Kα) = 0.71073 Å, µ = 9.128 mm
–1
, 10682 reflections collected, 
2801 unique (Rint = 0.0957), R1 [I > 2σ(I)] = 0.0297, wR2 (F, all 
data) = 0.0698, GoF = 1.003. 
CCDC-1401095 (1a), -1401096 (1b), -1401097 (5a), -1401098 
(5b), and -1400366 (9) contain the supplementary 
crystallographic data for this paper. These data can be 
obtained free of charge from The Cambridge Crystallographic 
Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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